Skip to main content

Table 1 Clinical and biochemical characteristics of T1D patients

From: Autoimmune thyroiditis and celiac disease do not worsen endothelial function in subjects with type 1 diabetes: an observational study

Variable

T1D without AT and CD

T1D with AT and or CD

p

Number

69

41

Age (y)

38 ± 13

35 ± 14

0.34

Gender (Female %)

39

61

0.02

Disease duration (y)

16 ± 9

18 ± 10

0.33

Age at the onset of diabetes (y)

21 ± 13

16 ± 12

0.09

HbA1c (%)

7.8 ± 1.2

7.6 ± 0.8

0.34

FPG (mg/dL)

162 ± 68

136 ± 67

0.09

Body weight (kg)

74 ± 12

69 ± 14

0.06

Waist (cm)

91 ± 11

89 ± 14

0.51

BMI (kg/m2)

26 ± 4

25 ± 5

0.26

Total cholesterol (mg/dL)

170 ± 34

165 ± 26

0.34

Triglycerides (mg/dL)

91 ± 53

67 ± 24

0.05

HDL-cholesterol (mg/dL)

57 ± 13

62 ± 13

0.11

LDL-cholesterol (mg/dL)

95 ± 32

89 ± 21

0.33

SBP (mmHg)

130 ± 20

131 ± 16

0.69

DBP (mmHg)

74 ± 10

75 ± 10

0.81

HR (bpm)

73 ± 12

77 ± 20

0.24

CSII (%)

35

56

0.02

CGM (%)

42

48

0.31

Hypertension (%)

14

12

0.49

Hyperlipidemia (%)

22

7

0.04

Retinopathy (%)

21

17

0.37

Nephropathy (%)

9

5

0.37

Neuropathy (%)

12

14

0.43

Macroangiopathy (%)

0

0

1

  1. Data are mean ± SD and percentage
  2. AT autoimmune thyroiditis, CD celiac disease, HbA1c glycated hemoglobin, FPG fasting plasma glucose, BMI body mass index, HDL high-density lipoprotein, LDL low-density lipoprotein, SBP systolic blood pressure, DBP diastolic blood pressure, HR heart rate, CSII continuous subcutaneous insulin infusion, CGM continuous glucose monitoring